We identified minor FLT3-ITDmut subclones at the time of initial AML diagnosis, expressing the CD34/CD123/CD25/CD99+ immunophenotype, in 83% of cases with a FLT3-ITDmut relapse8,9. The gene discussed is CD34; the disease is acute myeloid leukemia.